According to TScan Therapeutics's latest financial reports the company's current earnings are C$12.2 Million. In 2023 the company made an earning of -C$0.13 Billion a decrease over its 2022 earnings that were of -C$91.59 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.